SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : NGL Fine-Chem Ltd

BSE: 524774 NSE: NGLFINE ISIN: INE887E01022
  |   Sector:  Healthcare   |   Industry:  Pharmaceuticals & Drugs

Snapshot

Q.1 Which industry/sub-sector does NGL Fine-Chem Ltd belong to?
NGL Fine-Chem Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.2 Is NGL Fine-Chem Ltd a good quality company?
NGL Fine-Chem Ltd is a average quality company, based on a somewhat consistent 10 year financial track record.
Q.3 Is NGL Fine-Chem Ltd undervalued or overvalued?
NGL Fine-Chem Ltd appears Fair, as its key valuation ratios are in line with their past averages.
Q.4 Is NGL Fine-Chem Ltd a good buy now?
NGL Fine-Chem Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of NGL Fine-Chem Ltd?
NGL Fine-Chem Ltd revenue growth is 9.2% for FY-2025 , which is below its 5 year CAGR of 18.8% , indicating slower growth.
Q.2 Gross Profit margin of NGL Fine-Chem Ltd?
NGL Fine-Chem Ltd Gross profit margin which is the profit after deduction of direct costs, is 9.2% for FY-2025 , which is below its 5 year median of 17.9% , indicating decreasing margins.
Q.3 Operating Profit Margin of NGL Fine-Chem Ltd?
NGL Fine-Chem Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 7.4% for FY-2025 , which is below its 5 year median of 13.61% indicating decreasing margins.
Q.4 Net Profit Margin of NGL Fine-Chem Ltd?
NGL Fine-Chem Ltd Net Profit Margin is 5.05% for FY-2025 , is below with its 5 year median of 11.71%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin 9.2 17.9
Operating Profit Margin 7.4 13.61
Net Profit Margin 5.05 11.71
Q.5 Return on Asset of NGL Fine-Chem Ltd?
NGL Fine-Chem Ltd Return on Asset is 4.66%, which is below its 5 year historical median of 12.02%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of NGL Fine-Chem Ltd?
NGL Fine-Chem Ltd Return on equity is 6.69% for FY-2025 , which is below its historical median of 15.78%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of NGL Fine-Chem Ltd?
NGL Fine-Chem Ltd Return on capital employed is 8.29% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of NGL Fine-Chem Ltd?
NGL Fine-Chem Ltd Cash conversion cycle is 73 days, below its historical median of 74 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.92 1.03
ROE 6.69 15.78
ROCE 8.29 18.93
Cash Conversion Cycle 73 days 74 days
Q.9 Debt to Equity ratio of NGL Fine-Chem Ltd?
NGL Fine-Chem Ltd Debt-to-Equity ratio is 0.27 , which is above with the industry average of 0.15 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of NGL Fine-Chem Ltd?
NGL Fine-Chem Ltd Debt to cash flow from operations is 4.47 , which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of NGL Fine-Chem Ltd?
Promoters hold 72.74% of the NGL Fine-Chem Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of NGL Fine-Chem Ltd vs industry peers?
NGL Fine-Chem Ltd revenue CAGR is 18.75% , compared to the industry median CAGR of 5.54% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 359.3 137.1
Gross Profit 33 15.1
Operating Profit 27 16
Net Profit 18 5.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.92 0.8
ROE 6.69 8.91
ROCE 8.29 11.59
Cash Conversion Cycle (days) 72.56 76

Valuation & price assessment

Q.1 Stock return of NGL Fine-Chem Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 24.8% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 24.8% 5.7% 18.4% 109.6%
Q.3 Valuation ratios of NGL Fine-Chem Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 46.82 28.16 40.28
Price to Book 4.51 3.59 2.77
Price to Sales 3.19 2.59 2.65
EV to EBITDA 25.25 14.56 15.67

Check more companies

1. Ajanta Pharma
2. JB Chem & Pharma
3. Emcure Pharma
4. Gland Pharma
5. Wockhardt
6. Pfizer
7. Astrazeneca Pharma I
8. Sai Life Sciences
9. Natco Pharma
10. Eris Lifesciences
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×